OSRH earnings date and last-quarter result: next report 2026-09-02, last quarter miss, P/E -0.13. Updated 2026-07-23.
OSR Holdings (OSRH) Research Hub
OSR Holdings (OSRH) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-08-26, shares last closed at 0.168 USD (+43.59%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.13, market cap 0.01B. This hub links to the full technical, earnings and options research available for OSRH.
Last updated 2026-08-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.168 USD (+43.59%) |
| 52-week range | 0.075 USD – 0.8 USD |
| Trend regime | Range |
| 14-day RSI | 38.9 (Bearish) |
| Trailing P/E | -0.13 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-02 |
Available research for OSRH
Covered Call on OSRH: how it works, illustrative setup around the real 0.168 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on OSRH: how it works, illustrative setup around the real 0.168 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on OSRH: how it works, illustrative setup around the real 0.168 USD price, max profit/loss, breakeven and when to use it. Educational.
OSRH technical analysis: range, last 0.168 USD, RSI 38.9, 52w range 0.075 USD–0.8 USD, real support/resistance. Updated 2026-08-26.
More on SniperIQ
Frequently asked questions
What sector is OSRH in?
OSR Holdings (OSRH) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is OSRH in an uptrend or downtrend?
As of 2026-08-26, OSRH is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is OSRH's trailing P/E ratio?
OSRH's trailing P/E is -0.13, with a market cap of 0.01B. See the earnings research page for full valuation detail.
When does OSRH next report earnings?
OSRH is next scheduled to report earnings on 2026-09-02.